1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Germany >
  6. BioNTech >
  7. M&A

BioNTech Mergers & Acquisitions

BioNTech M&A Summary

BioNTech has acquired 6 companies, including 5 in the last 5 years. A total of 2 acquisitions came from private equity firms.

BioNTech’s largest acquisition to date was in 2025, when it acquired CureVac SE for $1.3B. BioNTech has acquired in 2 different US states, and 4 countries. The Company’s most targeted sectors include life science (84%) and software (17%).

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity6
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 4

BioNTech

BioNTech SE

An der Goldgrube 12,
Mainz, 55131
Germany,
+49 6131 9084 0
www.biontech.de

All (6) Buy (6) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-06-12 CureVac · Life Science
Tuebingen, Germany · www.curevac.com

CureVac is a multinational biotech company that advances the field of messenger RNA (mRNA) technology for application in human medicine. The company's mRNA platform incorporates a series of novel technologies, designed to improve the efficacy, safety and cost-effectiveness of mRNA therapeutics aimed at resulting in enhanced immune responses at lower doses. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer vaccine product candidates. It also develops programs in prophylactic vaccines and in treatments that aim to enable the human body to produce its own therapeutic proteins. Formed in 2000, CureVac is headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S.

Advisors: Goldman Sachs , NautaDutilh , Skadden, Arps, Slate, Meagher & Flom 		1,250 Add-on Acquisition

BioNTech
Advisors: Covington & Burling , Hengeler Mueller , Loyens & Loeff , PJT Partners

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal